Pfizer wraps deal for GSK's meningococcal vaccines; Indivior to fight Sandoz's suboxone copycat plans;

> Pfizer ($PFE) wrapped up its $130 million buyout of two GlaxoSmithKline ($GSK) meningococcal vaccines, Nimenrix and Mencevax. Report

> Indivior plans to sue Novartis' ($NVS) generics unit Sandoz for patent infringement after the latter filed for FDA approval for a copycat version of suboxone sublingual film. Report

> A new Cuban vaccine against hepatitis B is going through the process of clinical evaluation in 8 Asian countries in alliance with the French company Abivax. Report

> Diabetes drugs made by Novo Nordisk ($NVO) in partnership with the Algerian pharma Saidal will begin to be exported from that country beginning next year. Report

And Finally... Following European regulators, Brazil halted the use of breast implants made by a domestic devicemaker Silimed. Report

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.